Viewing nowNew Pacler Capsule (Cefaclor Hydrate)
Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Anguk New Pharm Co., Ltd.

MFDS item code 201602800 · Approved 2016.05.23 · Insurance code 053600260
Treatment of respiratory and urinary tract infections such as otitis media and pneumonia
This medication is effective against various bacteria, including Streptococcus pneumoniae and Haemophilus influenzae, which cause pneumonia. It is used for respiratory infections such as otitis media, pneumonia, pharyngitis, tonsillitis, and bronchitis. It is also effective for urinary tract infections such as pyelonephritis, cystitis, and gonococcal urethritis. It is used for skin infections such as boils, carbuncles, folliculitis, soft tissue infections, infectious gangrene, subcutaneous abscesses, impetigo, and wound infections. It is widely used for these various infectious diseases to improve patients' symptoms and aid in infection treatment.
As cefaclor hydrate, take 250mg (potency) orally every 8 hours. In cases of severe infections (such as pneumonia) and infections with low sensibility, dosages can be increased to twice the normal. In acute gonococcal urethritis, this drug 3g should be administered in a one-time combination with probenecid 1g.
Administer 20mg (potency) per kg of body weight once daily, divided every 8 hours. In cases of severe infections, otitis media, and infections with low sensibility, doses of up to 40mg (potency) per kg of body weight can be administered, with a maximum dose of.
This drug is an antibiotic that kills bacteria by binding to certain proteins and disrupting the synthesis of bacterial cell walls. Patients who have experienced severe allergic reactions or shock from this drug in the past should not use it. It is also safe to avoid administering this drug to patients who have an allergy to this drug or to similar classes of antibiotics. Patients with a history of allergy to penicillin antibiotics, those with allergic tendencies, patients with severely impaired kidney function, patients who have difficulty swallowing, elderly patients, and those with a history of gastrointestinal disease should use this drug with special caution. This drug can rarely cause shock or severe allergic reactions, so symptoms should be closely monitored during administration, and if abnormal symptoms appear, treatment should be discontinued immediately and appropriate care should be sought. There can be severe skin reactions, blood abnormalities, liver or kidney dysfunctions, and gastrointestinal problems, so it is important to regularly check the condition. This drug may interact with other medications; patients taking medications that affect the kidneys, anticoagulants, or oral contraceptives should inform healthcare providers. Women who are pregnant or breastfeeding should use this drug cautiously, as its safety has not been fully established, and careful attention is also necessary while breastfeeding. It is recommended to avoid using this drug in infants less than one month old, as its safety has not been confirmed. Elderly patients may experience adverse reactions more easily due to weakened body functions, so monitoring should be done carefully with adjustments in dosage and administration intervals. This drug can affect the results of some tests, so it is necessary to inform healthcare providers during examinations. It is recommended to administer this drug only for the appropriate duration to prevent the emergence of bacterial resistance. Before taking this drug, it is essential to consult with healthcare providers regarding past medical history and currently used medications to ensure safe usage.
Urticaria, severe swelling (edema), difficulty breathing, rash, blistering, skin peeling, mucosal pain in the mouth/eyes, Stevens-Johnson syndrome, toxic epidermal necrolysis, liver dysfunction (jaundice), sudden and severe headache, seizures, confusion, visual disturbances, paralysis, markedly reduced urine output, severe generalized edema with accompanying hypertension, shock, anaphylactic symptoms, interstitial pneumonia, eosinophilic pulmonary infiltration, acute renal failure, severe.
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it should be stored in a sealed container. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help maintain the drug's effectiveness and prevent deterioration.
A capsule with a light yellow powder, with a purple upper part and a white lower part.
30 capsules, 300 capsules
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCefaclor Hydrate 250mg
Hard capsule · Prescription medication
Anguk New Pharm Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Kolon Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 2.5g
Syrup · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.